Novavax, Inc. (LON:0A3S)
8.01
-0.06 (-0.74%)
At close: Sep 10, 2025
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
827.05K GBP
Profits / Employee
324.18K GBP
Market Cap
997.45M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 952 | -591 | -38.30% |
Dec 31, 2023 | 1,543 | -449 | -22.54% |
Dec 31, 2022 | 1,992 | 451 | 29.27% |
Dec 31, 2021 | 1,541 | 749 | 94.57% |
Dec 31, 2020 | 792 | 624 | 371.43% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
HSBC Holdings | 211,304 |
Shell | 96,000 |
Unilever | 115,964 |
Rolls-Royce Holdings | 42,400 |
British American Tobacco p.l.c. | 48,989 |
Rio Tinto Group | 60,000 |
BP p.l.c. | 100,500 |